Gateway 2011:Natoli Engineering Company, Inc
Your online Gateway to Natoli Engineering Company, Inc. in 2011
28 Research Park Circle
St. Charles, MO 63304
636-926-8900
Fax: 636-926-8910
www.natoli.com
About Natoli Engineering Company, Inc.
Natoli Tooling
Natoli has provided top quality tablet compression tooling for over 35 years and have grown to offer an extensive line of products and services to assist all stages of the tablet production process. No other company in the industry offers a more complete range of products and services, and their commitment to innovation and excellence has earned them an international reputation for high quality and reliability.
Natoli offers world-renowned tablet compression tooling, tablet presses, press refurbishing services, replacement parts and turrets, punch inspection systems and software, Light Induced Fluorescence (LIF) Sensor, technical training courses, and an all-new Tablet Compression Accessories Catalog.
Light Induced Fluorescence (LIF) Sensor
Natoli Engineering Company, Inc. invites you to join us at Interphex 2011. We will be showcasing our newest product, the Light Induced Fluorescence (LIF) Sensor. As a valuable new analytical process technology, the LIF Sensor was designed for process cleaning validation, liquid applications and blend uniformity endpoint monitoring. Stop by our booth to see a product demonstration and speak with one of our experts about what the LIF Sensor can do for you!
For more information:
info@natoli.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
